Calidi Biotherapeutics stock tumbles on $2M securities offering

seekingalpha10-23

Calidi Biotherapeutics (NYSE:CLDI) shares fell over 10% Wednesday morning after the company priced an offering of 2.05M common shares at $1.00 per share. The clinical-stage biotechnology company also ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2477353170?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-23 21:30","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2477353170","market":"hk","top_or_hot":-1,"title":"Calidi Biotherapeutics stock tumbles on $2M securities offering","media":"seekingalpha","content":"<div>\n<p>Calidi Biotherapeutics (NYSE:CLDI) shares fell over 10% Wednesday morning after the company priced an offering of 2.05M common shares at $1.00 per share. The clinical-stage biotechnology company also ...</p>\n\n<a href=\"https://seekingalpha.com/news/4194797-calidi-biotherapeutics-tumbles-on-2m-direct-offering\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Calidi Biotherapeutics stock tumbles on $2M securities offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCalidi Biotherapeutics stock tumbles on $2M securities offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-23 21:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4194797-calidi-biotherapeutics-tumbles-on-2m-direct-offering><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Calidi Biotherapeutics (NYSE:CLDI) shares fell over 10% Wednesday morning after the company priced an offering of 2.05M common shares at $1.00 per share. The clinical-stage biotechnology company also ...</p>\n\n<a href=\"https://seekingalpha.com/news/4194797-calidi-biotherapeutics-tumbles-on-2m-direct-offering\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLDI","symbol_name":"CALIDI BIOTHERAPEUTICS INC","start_time":0,"source_url":"https://seekingalpha.com/news/4194797-calidi-biotherapeutics-tumbles-on-2m-direct-offering","article_id":"2477353170","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477353170","pubTimestamp":1729690235,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Calidi Biotherapeutics  shares fell over 10% Wednesday morning after the company priced an offering of 2.05M common shares at $1.00 per share. The clinical-stage biotechnology company also entered into a concurrent private placement to issue series E warrants to purchase up to 2.05M common shares and series F warrants to purchase up to 2.05M common shares. The series E warrants have an exercise price of $1.13 per share, while the series F warrants are exercisable at $1.13 per share. The gross proceeds from the offerings are expected to be approximately $2M. Calidi  intends to use the net proceeds for working capital, general corporate purposes and pre-clinical and clinical trials. Shares of the biotech firm were down more than 10% in premarket trading on Wednesday.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLDI":"CALIDI BIOTHERAPEUTICS INC","BK4139":"生物科技"},"translate_title":"Calidi Biotherapeutics股价因发行200万美元证券而暴跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLDI":0.9},"content_text":"Calidi Biotherapeutics (NYSE:CLDI) shares fell over 10% Wednesday morning after the company priced an offering of 2.05M common shares at $1.00 per share. The clinical-stage biotechnology company also entered into a concurrent private placement to issue series E warrants to purchase up to 2.05M common shares and series F warrants to purchase up to 2.05M common shares. The series E warrants have an exercise price of $1.13 per share, while the series F warrants are exercisable at $1.13 per share. The gross proceeds from the offerings are expected to be approximately $2M. Calidi (CLDI) intends to use the net proceeds for working capital, general corporate purposes and pre-clinical and clinical trials. Shares of the biotech firm were down more than 10% in premarket trading on Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477353170"}